Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor–based Immunotherapy

Life Science Alliance - United States
doi 10.26508/lsa.201800265
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Life Science Alliance, LLC

Related search

A CDK9 Inhibitor May Suppress Tumor Growth and Enhance Immunotherapy

Cancer Discovery
Oncology
2018English

Macrophage Checkpoint Blockade and Tumor Mechanics in a Cell-Based Immunotherapy

Biophysical Journal
Biophysics
2019English

Inhibition of Gastric Tumor Growth by a Novel Hsp90 Inhibitor

Biochemical Pharmacology
BiochemistryPharmacology
2013English

Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy

Mayo Clinic Proceedings
Medicine
2019English

Local Angiotensin II Contributes to Tumor Resistance to Checkpoint Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

A Tumor-Peptide Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Anti-Tumor Immunotherapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis in Vivo and Inhibition Enhances Anti-Vegf Therapy

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy